<DOC>
	<DOCNO>NCT01242137</DOCNO>
	<brief_summary>Glibenclamide metabolize hepatic enzyme P450 CYP2C9 less active form . Polymorphism enzyme demonstrate clinical significance examine drug sulfonylurea drug family , Glibenclamide include . The investigator assumption patient less active allele enzyme may show low dose requirement drug glycemic control , compare patient homozygotes wild-type allele .</brief_summary>
	<brief_title>Pharmacogenetic Effect Pharmacodynamics Glibenclamide</brief_title>
	<detailed_description />
	<criteria>Tx metformin glibenclamide Tx affect P450 2C9 action Renal failure</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2010</verification_date>
</DOC>